Abstract: Slide Presentations |


Alain Tremblay, MD*; David R. Stather, MD; Paul MacEachern, MD; Severian Dumitriu, PhD; Lori Maxwell, RVT; Charity Green, FCSMLS; Margaret M. Kelly, MBChB
Author and Funding Information

University of Calgary, Calgary, AB, Canada


Chest. 2008;134(4_MeetingAbstracts):s66002. doi:10.1378/chest.134.4_MeetingAbstracts.s66002
Text Size: A A A
Published online


PURPOSE:Treatment of pleural effusions often consists of attempts at creating a pleural symphysis with a sclerosing agent, usually administered as a single bolus dose. We have previously demonstrated that low dose repeated administration of silver nitrate (SN) as compared to single high dose administration can lead to effective pleurodesis, but such dosing regimen would be impractical in patients.

METHODS:A catheter coating capable of eluting SN over 14 days was designed and tested in a well described in-vivo animal pleurodesis model. Three groups of six animals (SPF New Zealand white rabbits) underwent placement of uncoated, 24mg SN and 50mg SN catheters in the right pleural space. Catheters were removed on day 15 and necropsy performed on day 29. Efficacy of pleurodesis was assessed by a 1–8 score (1-normal, 8-pleural symphysis >50% hemithorax), with a score of ≥5 considered significant.

RESULTS:Mean pleurodesis scores on the treated (right) side were 1.0, 4.8 and 6.3 for the uncoated, 24mg and 50mg groups respectively (p= 0.001 vs. uncoated for each SN group). Scores for the untreated (left) side were 1.0, 1.0 and 1.6 for the uncoated, 24mg and 50mg groups respectively.

CONCLUSION:A SN eluting coated catheter appears to be effective in creating pleurodesis.

CLINICAL IMPLICATIONS:This approach could potentially be useful in achieving pleurodesis on an outpatient basis for patients with a variety of pleural diseases. The use of lower peak doses of sclerosing agents may also reduce the frequency and severity of side-effects.

DISCLOSURE:Alain Tremblay, None.

Wednesday, October 29, 2008

10:30 AM - 12:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

CHEST Journal Articles
PubMed Articles
Advances in the management of malignant pleural effusion. Curr Opin Pulm Med Published online Apr 19, 2017;
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543